These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9207268)

  • 1. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis.
    Boehme MW; Autschbach F; Zuna I; Scherbaum WA; Stange E; Raeth U; Sieg A; Stremmel W
    Gastroenterology; 1997 Jul; 113(1):107-17. PubMed ID: 9207268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
    Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
    Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
    Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
    Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease.
    Srivastava M; Zurakowski D; Cheifetz P; Leichtner A; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2001 Nov; 33(5):548-53. PubMed ID: 11740227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.
    Manon-Jensen T; Sun S; Lindholm M; Domislović V; Giuffrida P; Brinar M; Mazza G; Pinzani M; Krznarić Z; Di Sabatino A; Karsdal MA; Mortensen JH
    United European Gastroenterol J; 2021 Mar; 9(2):268-278. PubMed ID: 33351719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating von Willebrand factor in inflammatory bowel disease.
    Stevens TR; James JP; Simmonds NJ; McCarthy DA; Laurenson IF; Maddison PJ; Rampton DS
    Gut; 1992 Apr; 33(4):502-6. PubMed ID: 1582595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease.
    Weber P; Husemann S; Vielhaber H; Zimmer KP; Nowak-Göttl U
    J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):418-22. PubMed ID: 10204507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease.
    Griga T; Tromm A; Spranger J; May B
    Scand J Gastroenterol; 1998 May; 33(5):504-8. PubMed ID: 9648990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
    Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
    Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
    Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
    Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nitrate levels in ulcerative colitis and Crohn's disease.
    Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
    Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease.
    Bousvaros A; Leichtner A; Zurakowski D; Kwon J; Law T; Keough K; Fishman S
    Dig Dis Sci; 1999 Feb; 44(2):424-30. PubMed ID: 10063933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
    Kull K; Salupere R; Uibo R; Ots M; Salupere V
    Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
    Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecules in inflammatory bowel disease.
    Jones SC; Banks RE; Haidar A; Gearing AJ; Hemingway IK; Ibbotson SH; Dixon MF; Axon AT
    Gut; 1995 May; 36(5):724-30. PubMed ID: 7541009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
    Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
    Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.